Search Orphan Drug Designations and Approvals
-
Generic Name: | cannabidiol (CBD) |
---|---|
Date Designated: | 10/24/2017 |
Orphan Designation: | Treatment of Lennox-Gastaut syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AXIUM Pharmaceuticals, Inc. 265 Eastchester Drive Suite 133, #201 High Point, North Carolina 27262 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-